Source: ERJ Open Res, 8 (1) 00485-2021; 10.1183/23120541.00485-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Caroline Hurabielle, Camille Taillé, Grégoire Prévot, Maud Russier, Alain Didier, Pierre-Olivier Girodet, Magali Colombat, Julien Mazières, Laurent Guilleminault. De-labelling severe asthma diagnosis: the challenge of DIPNECH. ERJ Open Res, 8 (1) 00485-2021; 10.1183/23120541.00485-2021

Member's Comments

No comment yet.

Related content which might interest you: When asthma diagnosis becomes a challenge Source: Eur Respir J 2010; 36: 231 Year: 2010 Severe asthma: approach to diagnosis and treatment Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Severe asthma: classification and treatment Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Specific nasal challenge in the diagnosis of alternaria-induced asthma Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011 Re-evaluation of asthma diagnosis in patients with adult-onset asthma Source: International Congress 2017 – New research in asthma and COPD Year: 2017 Immunotherapy in severe asthma Source: ERS webinar 2021: Immunotherapy in severe asthma Year: 2021 Bronchiectasis as a serious problem in children: ethiology, diagnosis and symptoms Source: Eur Respir J 2004; 24: Suppl. 48, 392s Year: 2004 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults Source: Eur Respir J 2007; 30: Suppl. 51, 587s Year: 2007 Defining asthma and COPD: differential diagnosis Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018 Nasal symptoms and doctor-diagnosed chronic lung diseases Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 The challenge of defining exacerbation in bronchiectasis Source: Eur Respir J, 49 (6) 1700700; 10.1183/13993003.00700-2017 Year: 2017 Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Severe asthma: one disease many definitions Source: International Congress 2019 – Asthma and the world Year: 2019 Diagnostic value of specific nasal provocation in the diagnosis of allergic rhinitis in mild persistent asthma cases Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Bronchial challenge test in patients with chronic persistent cough and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 475s Year: 2003